Document ID: chunk:federal_register_of_legislation:F2013C00288:reg:11:p3
Version: federal_register_of_legislation:F2013C00288
Segment Type: reg
Provision Reference: reg 11 (pt 3/3)
Character Range: 2586581–2589116

Classification
1.4.2 Review of Available Values/Information
1.4.3 Recommendation
1.5 Calculated HILs
1.6 References
2 2,4-D
2.1 General
2.2 Previous HIL
2.3 Significance of Exposure Pathways
2.3.1 Oral Bioavailability
2.3.2 Dermal absorption
2.3.3 Inhalation of Dust
2.3.4 Plant Uptake
2.3.5 Intakes from Other Sources – Background
2.4 Identification of Toxicity Reference Values
2.4.1 Classification
2.4.2 Review of Available Values/Information
2.4.3 Recommendation
2.5 Calculated HILs
2.6 References
3 MCPA, MCPB and Mecoprop
3.1 General
3.2 Previous HIL
3.3 Significance of Exposure Pathways
3.3.1 Oral Bioavailability
3.3.2 Dermal absorption
3.3.3 Inhalation of Dust
3.3.4 Plant Uptake
3.3.5 Intakes from Other Sources – Background
3.4 Identification of Toxicity Reference Values
3.4.1 Classification
3.4.2 Review of Available Values/Information
3.4.2.1 MCPA
3.4.2.2 MCPB
3.4.2.3 Mecoprop (MCPP)
3.4.3 Recommendation
3.5 Calculated HILs
3.6 References
4 Picloram
4.1 General
4.2 Previous HIL
4.3 Significance of Exposure Pathways
4.3.1 Oral Bioavailability
4.3.2 Dermal absorption
4.3.3 Inhalation of Dust
4.3.4 Plant Uptake
4.3.5 Intakes from Other Sources – Background
4.4 Identification of Toxicity Reference Values
4.4.1 Classification
4.4.2 Review of Available Values/Information
4.4.3 Recommendation
4.5 Calculated HILs
4.6 References
5 Atrazine
5.1 General
5.2 Previous HIL
5.3 Significance of Exposure Pathways
5.3.1 Oral Bioavailability
5.3.2 Dermal absorption
5.3.3 Inhalation of Dust
5.3.4 Plant Uptake
5.3.5 Intakes from Other Sources – Background
5.4 Identification of Toxicity Reference Values
5.4.1 Classification
5.4.2 Review of Available Values/Information
5.4.3 Recommendation
5.5 Calculated HILs
5.6 References
6 Chlorpyrifos
6.1 General
6.2 Previous HIL
6.3 Significance of Exposure Pathways
6.3.1 Oral Bioavailability
6.3.2 Dermal absorption
6.3.3 Inhalation of Dust
6.3.4 Plant Uptake
6.3.5 Intakes from Other Sources – Background
6.4 Identification of Toxicity Reference Values
6.4.1 Classification
6.4.2 Review of Available Values/Information
6.4.3 Recommendation
6.5 Calculated HILs
6.6 References
7 Bifenthrin
7.1 General
7.2 Previous HIL
7.3 Significance of Exposure Pathways
7.3.1 Oral Bioavailability
7.3.2 Dermal absorption
7.3.3 Inhalation of Dust
7.3.4 Plant Uptake
7.3.5 Intakes from Other Sources – Background
7.4 Identification of Toxicity Reference Values
7.4.1 Classification
7.4.2 Review of Available Values/Information
7.4.3 Recommendation
7.5 Calculated HILs
7.6 References
8 Shortened forms